Cargando…

Foreword: Focus on complex metallic phases

I am glad to learn that a focus issue, Complex Metallic Phases, will be published in Science and Technology of Advanced Materials (STAM). The articles in this special issue contain original and review papers on fundamentals and applications contributed by experts in the field. The topics cover vario...

Descripción completa

Detalles Bibliográficos
Autor principal:	Shechtman, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Focus on Complex Metallic Phases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099671/ https://www.ncbi.nlm.nih.gov/pubmed/27877710 http://dx.doi.org/10.1088/1468-6996/15/5/050302

Ejemplares similares

Preface: Focus on complex metallic phases
por: Tsai, An-Pang, et al.
Publicado: (2014)

Complex metallic alloys as new materials for additive manufacturing
por: Kenzari, Samuel, et al.
Publicado: (2014)

Friction and solid-solid adhesion on complex metallic alloys
por: Dubois, Jean-Marie, et al.
Publicado: (2014)

Surfaces of Al-based complex metallic alloys: atomic structure, thin film growth and reactivity
por: Ledieu, Julian, et al.
Publicado: (2014)

Metallic–covalent bonding conversion and thermoelectric properties of Al-based icosahedral quasicrystals and approximants
por: Takagiwa, Yoshiki, et al.
Publicado: (2014)

Deformation at ambient and high temperature of in situ Laves phases-ferrite composites
por: Donnadieu, Patricia, et al.
Publicado: (2014)

Tailoring microstructure of Mg–Zn–Y alloys with quasicrystal and related phases for high mechanical strength
por: Singh, Alok
Publicado: (2014)

Activation of Al–Cu–Fe quasicrystalline surface: fabrication of a fine nanocomposite layer with high catalytic performance
por: Kameoka, Satoshi, et al.
Publicado: (2014)

Quasicrystal-reinforced Mg alloys
por: Kyun Kim, Young, et al.
Publicado: (2014)

Intermetallic compounds in heterogeneous catalysis—a quickly developing field
por: Armbrüster, Marc, et al.
Publicado: (2014)

Photonic crystals, amorphous materials, and quasicrystals
por: Edagawa, Keiichi
Publicado: (2014)

Magnetism in icosahedral quasicrystals: current status and open questions
por: Goldman, Alan I
Publicado: (2014)

Very large thermal rectification in bulk composites consisting partly of icosahedral quasicrystals
por: Takeuchi, Tsunehiro
Publicado: (2014)

Foreword to the Focus Issue: Composite materials for functional electronic devices
por: Zhou, Ye
Publicado: (2022)

Foreword to the focus issue: materials and technologies for memristors and neuromorphic devices
por: Zhou, Ye, et al.
Publicado: (2023)

Foreword to the Focus Issue: science and technology of element-strategic permanent magnets
por: Hirosawa, Satoshi, et al.
Publicado: (2022)

Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer
por: Horinouchi, Hidehito, et al.
Publicado: (2015)

Phase I trial of volasertib, a Polo-like kinase inhibitor, plus platinum agents in solid tumors: safety, pharmacokinetics and activity
por: Awada, Ahmad, et al.
Publicado: (2015)

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)
por: Keizer, Ron J., et al.
Publicado: (2011)

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [(14)C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors
por: Zhou, Xiaofei, et al.
Publicado: (2020)

Ferrocene derivatives with planar chirality and their enantioseparation by liquid‐phase techniques
por: Peluso, Paola, et al.
Publicado: (2022)

Eribulin mesylate in patients with refractory cancers: a Phase I study
por: Mukohara, Toru, et al.
Publicado: (2011)

Patient-Reported Physician Treatment Recommendations and Compliance Among U.S. Adults with Low Back Pain
por: Goertz, Christine M., et al.
Publicado: (2021)

Phase II study of sunitinib as second-line treatment for advanced gastric cancer
por: Bang, Yung-Jue, et al.
Publicado: (2010)

A phase Ib study of everolimus combined with metformin for patients with advanced cancer
por: Molenaar, Remco J., et al.
Publicado: (2017)

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors
por: Puzanov, Igor, et al.
Publicado: (2014)

Phase I study of enzastaurin and bevacizumab in patients with advanced cancer: safety, efficacy and pharmacokinetics
por: Nwankwo, Nwabundo, et al.
Publicado: (2012)

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics
por: Sunakawa, Yu, et al.
Publicado: (2013)

Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies
por: Smith, David C., et al.
Publicado: (2015)

Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer
por: van der Noll, R., et al.
Publicado: (2015)

Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors
por: Annunziata, Christina M., et al.
Publicado: (2012)

Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors
por: Naing, Aung, et al.
Publicado: (2013)

Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer
por: Tolaney, Sara M., et al.
Publicado: (2015)

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors
por: Yamamoto, Noboru, et al.
Publicado: (2016)

Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemia
por: Uy, Geoffrey L., et al.
Publicado: (2020)

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer
por: Boku, Narikazu, et al.
Publicado: (2013)

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
por: Ito, Tetsuhide, et al.
Publicado: (2013)

Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease
por: Yau, Thomas, et al.
Publicado: (2012)

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer
por: Doi, Toshihiko, et al.
Publicado: (2015)

Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors
por: Ito, Tetsuhide, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jg6mkqvegsl8b474j9vrv3flnj